Changing regulatory guidance on generic topical products is expected to lead to an increase in the number of market approvals in the near future.
Jeremy Drummond
Advertisement
Dr. Jeremy Drummond is senior vice-president of business development for MedPharm.
Articles by Jeremy Drummond
Advertisement
Latest Updated Articles
Getting in Touch with New Guidance on Topical ProductsOctober 2nd 2019
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
FDA Guidance for Accelerating Gene Therapies for Rare Diseases
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5